You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Institute Director Eric Green noted that a lack of diversity in the scientific and clinical workforce has negative consequences for how research is conducted.
Wired speaks with National Human Genomics Research Institute's Eric Green about the Human Genome Project.
NHGRI has moved the Genotype-Tissue Expression dataset entirely to the cloud in an effort to democratize access to the huge but formerly pricey compendium.
Jackson Laboratory researchers will lead an interdisciplinary team of experts to study the employee health benefits of workplace genetic testing.
Green and his NHGRI colleagues published a strategic vision for human genomics research, emphasizing data science, implementation of genomics, and human diversity.
As part of the strategy paper, the institute also compiled a list of 10 bold predictions for human genomics that might come true by 2030.
Since the mutations are only found in a subset of patients' blood cells, the disorder, called VEXAS, might be treatable with a bone marrow transplant.
The funding will help the San Francisco-based firm apply low-depth NGS as it builds diagnostic tests to aid therapy selection in more diverse populations.
A genetic analysis of Australian labradoodles finds they are mostly poodles, the Guardian reports.
The de novo directional genomic hybridization technology is designed to enable the measurement of simple, complex, and heterogenous structural variants.
According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.
Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.
In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.
Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.